Differential effects of anti-Fc gamma RIIIb autoantibodies on polymorphonuclear neutrophil apoptosis and function.
Anti-Fc gamma receptor IIIb (Fc gammaRIIIb) human autoantibodies (Ab) have been classified previously into three groups, based on the results of an indirect immunofluorescence (IIF) test and an enzyme-linked immunosorbent assay (ELISA): IIF+/ELISA+ (group A), IIF+/ELISA- (group B), and IIF-/ELISA+ (group C) sera. In this study, differential effects between IIF+ autoAb, recognizing cell-bound Fc gammaR, and those ELISA+, recognizing only cell-free Fc gammaR, were studied on polymorphonuclear neutrophils (PMN). Neither group A nor B autoAb was cytotoxic, although both prolonged the survival of PMN by delaying spontaneous apoptosis. By the same extent, the PMN-binding antisera stimulated the appearance of a CD11b(dim) population, following a 12-h incubation. This event was associated with a lowered expression of beta2 integrin molecules, resulting in altered PMN function. Treatment with groups A and B autoAb reduced adhesiveness and respiratory burst. This impairment of the responses was more pronounced when the cells originated from donors NA1+ NA1+ rather than donors NA2+ NA2+. From our observations, the influences of anti-Fc gammaRIIIb autoAb on PMN survival, as well as function and subsequent dysregulation of the inflammatory response, have proven somewhat dependent on their target antigens, as determined by IIF coupled with ELISA and Fc gammaRIIIb polymorphism.
Laboratory of Immunology, Institut de Synergie des Sciences et de la Santé, Brest University Medical School, France.
V
V
Durand
J O
JO
Pers
Y
Y
Renaudineau
A
A
Saraux
P
P
Youinou
C
C
Jamin
D000920:Antibody-Dependent Cell Cytotoxicity; D017209:Apoptosis / Q000276:immunology*; D001172:Arthritis, Rheumatoid / Q000276:immunology / Q000473:pathology; D001323:Autoantibodies / Q000097:blood / Q000494:pharmacology*; D002448:Cell Adhesion / Q000276:immunology; D002462:Cell Membrane / Q000276:immunology / Q000378:metabolism; D003602:Cytotoxicity, Immunologic; D006801:Humans; D007111:Immunity, Cellular; D016130:Immunophenotyping; D008180:Lupus Erythematosus, Systemic / Q000276:immunology / Q000473:pathology; D009504:Neutrophils / Q000166:cytology* / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D017452:Receptors, IgG / Q000097:blood / Q000276:immunology*; D012859:Sjogren's Syndrome / Q000276:immunology / Q000473:pathology; D012995:Solubility
D001323:Autoantibodies; D017452:Receptors, IgG